>Praa.g_00494 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MNYIKVKGLSKSYSDINALKNLSIEIEAGTLFGILGPNGAGKSTLIKILATLIEPDSGEV
FINNINLIRNSRKIRELIGYVAQDIALDKILTGRELLDFQSDLYHINKNKKFERINKLID
QLEMNDWIDRKCGTYSGGMKRRIDLAAGLLHLPQVLILDEPTVGLDIESRNIIWQLLKDL
RNNGMTIILSSHYLDEIDKLADRLVIIDDGRVIAKGTPAELKNKLGGDRVTLKVREFSNQ
EEAKNICQILSSIDGISQIIINEAQGFSVNFIAEKGKDLLTKLKVELAFSKFEIFSLTQS
QPSLDDVYLQATGKTLLDAEISMAGKRDLKKESKQSMR*
>Prab.g_00498 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MNYIQIKDLSKSYSDIKALKNLSMEINAGTLFGILGPNGAGKSTLIKILATLVEPDGGEV
FVNNINLIKNPRKIRELIGYVAQDIALDKILTGRELLDFQSDLYHMNKKEKYERIKLLIN
QLEMNDWIDRKCGTYSGGMKRRIDLAAGLLHLPKVLILDEPTVGLDIESRNIIWQLLKDL
KNDGMTIILSSHYLDEIDKLADSLVIIDDGKVIAQGTPAQLKNKLGGDRITLKVREFSNH
EESKKISEILSSINGISQIIINKAQGYAINFVVDKEKDLLTKLKVELAFSKFEIFSLAQS
QPSLDDVYLQATGKTLLDAEISMTGKRDLKKESKQSMR*
>Prae.g_00468 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MNYIKVKGLSKSYSDINALKNLSMEIQAGTLFGILGPNGAGKSTLIKILATLIEPDSGEV
FINNINLIKNSRKIRELIGYVAQDIALDKILTGRELLDFQSDLYHINKNKKFERINQLID
QLEMNDWIDRKCGTYSGGMKRRIDLAAGLLHLPQVLILDEPTVGLDIESRNIIWQLLKDL
RNNGMTIILSSHYLDEIDKLADRLVIIDDGRVIAKGTPAELKNKLGGDRVTLKVREFSNQ
EEAKNICKILSSIDGISQIIINEAQGFSINFVANKQKDLLTKLKVELAFSKFEIFSLTQS
QPSLDDVYLQATGKTLLDAEISMAGKRDFKKESKQSMR*
>Praf.g_00611 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MIELKQLEKSYGTVQALKGLSLKVPRGCLYGLLGPNGAGKTTTLRILCTLLAPDSGTVSV
AGLDALSDPRAVRLELGYVAQEVAIDKILTGRELLQLQGDLYHLRSSDRDGRIAELIDCL
GMQDWIDRRCGTYSGGMRRRIDLASGLLHQPQLLVLDEPTVGLDIESRSAIWQLLRELRA
QGTTVLLSSHYLEEVEALADRMAIIDDGRVIAEGTPDQLKQQLGGDRVTLRVKEFSDDRE
AEQVRQLLQGVDGVRQVVVNRVQGFSLNLVVENEAVVPRLREQLDGAQLPVFALAHSRPS
LDDVYLQATGRTLMDAELAVAGQRDSKLERKKAMR*
>Prag.g_00473 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MNYIKVKELSKSYSDIEALKNLSMEIEAGTLFGILGPNGAGKSTLIKILATLIEPDSGEV
FINDINLIKNSRKIRELIGYVAQDIALDKILTGRELLDFQSDLYHINKNKKNERIQKLVD
QLEMNDWIDRKCGTYSGGMKRRIDLAAGLLHLPQVLILDEPTVGLDIESRNIIWQLLKDL
RNNGMTIILSSHFLDEIDKLADRLVIIDNGRVIAQGNPAELKNKLGGDRITLKVQEFSNQ
EEAENICQILSSIDGISQIIINEAQGFSINFVADKEKDLLTKLKVELAFSKFEIFSLTQS
QPSLDDVYLQATGKTLLDAEISMAGKRDLKKESKQSMR*
>Prah.g_01550 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MIELKQLEKSYGTVQALKGLSLKVPRGCLYGLLGPNGAGKTTTLRILCTLLAPDSGTVSV
AGLNALSDPRAVRLELGYVAQEVAIDKILTGRELLQLQGDLYHLRSSDRDGRIAELIDCL
GMQDWIDRRCGTYSGGMRRRIDLASGLLHQPQLLVLDEPTVGLDIESRSAIWQLLRELRA
QGTTVLLSSHYLEEVEALADRMAIIDDGRVIAEGTPDQLKQQLGGDRVTLRVKEFSDDRE
AEQVRQLLQGVDGVRQVVVNRVQGFSLNLVVENEEVVPRLREQLDGAQLPVFALAHSRPS
LDDVYLQATGRTLMDAELAVAGQRDSKLERKKAMR*
>Prai.g_00524 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MNYIQITDLSKSYSDIEALKKLSMEINAGTLFGILGPNGAGKSTLIKILATLVEPDSGEV
FINNINLIKNPKKIRELIGYVAQDIALDKILTGRELLDFQSDLYHMKKKEKYERIKLLIK
QLDMNDWIDRKCGTYSGGMKRRIDLAAGLLHLPKVLILDEPTVGLDIESRNIIWNLLKDL
KNDGMTIILSSHYLDEIDKLADSLVIIDDGKVIAQGTPIQLKNKLGGDRITLKVREFSSD
EESKKICEILSSIDGISQIVTNKAQGYSLNFVVDKDKDLLTKLKVELAFSKFEIFSLAQS
QPSLDDVYLQATGKTLLDAEISMTGKRDLKKESKQSMR*
>Praj.g_00486 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MFFIKLRDLFKSYGPVMALNGLNLEVPKGSLYGLLGPNGAGKSTALRIICTLLSPDSGHV
EVGGHNVLFEEKETRRRLGYVAQDVAIDKILTGRELLELQGDLYHLDKKYKRRRIEELIE
RLDMHEWIDRRCGSFSGGMKRRLDLSSGLLHEPELLILDEPTVGLDIESRSVIWGLLKEL
RNKETTILLSSHYLEEVDELADEMAIIDKGKVIASGKPDDLKKELGGDRVTLRVREFSDE
VEAESVKKLIKNINGVSNVVVNQTQGYSLNFLVQSNDVISNLSGHLSKENFEVFALSHSR
PSLDDVYLQATGKTLMDAELELAGKRDFKLENKKSMR*
>Prak.g_00455 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MSFVELKDIEKSYGPVKALRKFTLSIPKGSLFGLLGPNGSGKSTTLRILCTLLEPDSGEV
IVGGENALKNPRGVRKKIGYVAQEVAIDKILSGRELLQLHGDLYHLPRTFRNSKIQELIA
RLDMSEWIDRRTGSYSGGMRRRLDLASGLMHEPELLVLDEPTVGLDIESRAAIWSLLREL
CADGTTILLSSHYLEEVDALSDQMAIIDSGKVIASGSPDELKSKLGNKRVSLKVREFSNE
EEAEKVKSIIENIKGLHDIILNRSQGFSLNFFADDSEPLNILRTQLTNAGYDIFALAESR
PSLDDVYLQATGQTLMDVELEIASKRDLKKEAKQAMR*
>Prat.g_00455 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MSLVELHDLVKSYGSVKALNKLSLRVPEGSLFGLLGPNGSGKSTTLRILCTLLAPDSGNA
IVAGVDVLKNPRYIRQNIGYVAQEIAIDKILSGRELLQLHGDLYHLSRNDRDLRIEELVR
QLEMGEWVDRRLGSYSGGMKRRLDLASGLLHQPKLLILDEPTVGLDIESRSTIWNLLRDL
REKGTTILLSSHYLEEVDALADQMAIIDKGQVIGYGSPQELKDKLGGNRITLKVREFSDE
RESEKIKQLVKEIEGVGKVVVNRAQGFSLNLVVDDQDVLQKLRAKLTESGFDVFALSESR
PSLDDVYLQATGRTIADVELEVAGKRDIKGEAKKSMR*
>Prau.g_00535 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MNYIKVTGLSKSYSDIKALKNLSMEIEAGTLFGILGPNGAGKSTLIKILATLIEPDSGEV
FINDINLIKNSRKIRELIGYVAQEIALDKILTGRELLDFQSDLYHINKNKKFERIKKLID
QLEMNDWIDRKCGTYSGGMKRRIDLAAGLLHLPQVLILDEPTVGLDIESRNIIWQLLKDL
RNNGMTIILSSHYLDEIDKLADRLVIIDDGRVIAQGAPAELKNKLGGDRVTLKVREFSNQ
EEAKNICQILSSIDGISQIIINEAQGFSINFVADKEKDLLTKLKVELAFSKFEIFSLTQS
QPSLDDVYLQATGKTLLDAEISMAGKRDLKKESKQSMR*
>Prbb.g_00498 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MFFIKLRDLFKSYGPVMALNGLNLEVPKGSLYGLLGPNGAGKSTALRIICTLLSPDSGHV
EVGGHNVLFEEKETRRRLGYVAQDVAIDKILTGRELLQLQGDLYHLDKKYKRKRIEELIE
RLDMHEWIDRRCGSFSGGMKRRLDLSSGLLHEPELLILDEPTVGLDIESRSVIWGLLKEL
RNKETTILLSSHYLEEVDELADEMAIIDKGKVIASGKPDDLKKELGGDRVTLRVREFSDE
VEAESVKKLIKNINGVSNVVVNQTQGYSLNFLVQSNDVISNLSGHLSKENFEVFALSHSR
PSLDDVYLQATGKTLMDAELELAGKRDFKLENKKSMR*
